These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 16698661)

  • 21. The prescription of hormone replacement therapy in Spain: differences between general practitioners and gynaecologists.
    Castelo-Branco C; Ferrer J; Palacios S; Cornago S
    Maturitas; 2006 Nov; 55(4):308-16. PubMed ID: 16730140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in U.S. prescribing patterns of menopausal hormone therapy, 2001-2003.
    Hing E; Brett KM
    Obstet Gynecol; 2006 Jul; 108(1):33-40. PubMed ID: 16816053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical guidelines for improving compliance with hormone therapy in Latin American women during the menopausal transition and thereafter.
    Maia H; Bossemeyer R; Espinosa-Larrañaga F; Murillo A; Siseles N
    Maturitas; 2007 Jan; 56(1):101-9. PubMed ID: 16889912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scientific evidence changes prescribing practice--a comparison of the management of the climacteric and use of hormone replacement therapy among Swedish gynaecologists in 1996 and 2003.
    Thunell L; Milsom I; Schmidt J; Mattsson LA
    BJOG; 2006 Jan; 113(1):15-20. PubMed ID: 16398765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Estonian and Finnish physicians' opinions of menopause and hormone therapy.
    Hovi SL; Karttunen T; Karro H; Hemminki E
    Maturitas; 2004 Oct; 49(2):107-13. PubMed ID: 15474754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hysterectomy--A female gynecologist's perspective.
    Logambal A
    Saudi Med J; 2000 Jan; 21(1):106-7. PubMed ID: 11533765
    [No Abstract]   [Full Text] [Related]  

  • 27. Life prevalence and determinants of hormone replacement therapy in women living in Porto, Portugal.
    Lucas R; Barros H
    Maturitas; 2007 Jul; 57(3):226-32. PubMed ID: 17293067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amended report from the NAMS Advisory Panel on Postmenopausal Hormone Therapy.
    North American Menopause Society
    Menopause; 2003; 10(1):6-12. PubMed ID: 12544671
    [No Abstract]   [Full Text] [Related]  

  • 29. Japan Society of Obstetrics and Gynecology and Japan Society for Menopause and Women's Health 2017 guidelines for hormone replacement therapy.
    Okano H; Higuchi T; Kurabayashi T; Makita K; Mizunuma H; Mochizuki Y; Obayashi S; Yasui T; Takamatsu K;
    J Obstet Gynaecol Res; 2018 Aug; 44(8):1355-1368. PubMed ID: 29957860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Practice patterns of some gynaecologists in Malaysia with regards to prophylactic oophorectomy and hormone replacement therapy.
    Ravindran J; Leow CH
    Med J Malaysia; 1996 Dec; 51(4):409-14. PubMed ID: 10968026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HRT, VTE and surgery: what is best practice?
    McLintock C
    N Z Med J; 2002 Jul; 115(1157):U65. PubMed ID: 12362199
    [No Abstract]   [Full Text] [Related]  

  • 32. Women's trust in and use of information sources in the treatment of menopausal symptoms.
    Huston SA; Jackowski RM; Kirking DM
    Womens Health Issues; 2009; 19(2):144-53. PubMed ID: 19272565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular health and the menopause: the gynecologist as the patients' interface.
    Arias RD
    Climacteric; 2006 Sep; 9 Suppl 1():6-12. PubMed ID: 16899438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Latin American position on the current status of hormone therapy during the menopausal transition and thereafter.
    Maia H; Albernaz MA; Baracat EC; Barbosa IC; Bossemeyer R; Bueno AH; Campos OG; Carranza-Lira S; Casas PF; Castro AM; de Lima GR; de Melo NR; Fernandes CE; González JS; Larrañaga FE; Siseles N; Uribe AM; Vilchez RM; Latin American Expert Panel
    Maturitas; 2006 Aug; 55(1):5-13. PubMed ID: 16675170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolving practice patterns and attitudes toward hormone therapy of obstetrician-gynecologists.
    Power ML; Schulkin J; Rossouw JE
    Menopause; 2007; 14(1):20-8. PubMed ID: 17019376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physicians' judgments about estrogen replacement therapy for menopausal women.
    Holzman GB; Ravitch MM; Metheny W; Rothert ML; Holmes M; Hoppe RB
    Obstet Gynecol; 1984 Mar; 63(3):303-11. PubMed ID: 6700852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Menopause 2000-2010.
    Charles J; Pan Y; Miller G
    Aust Fam Physician; 2011 May; 40(5):265. PubMed ID: 21597541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The menopausal marketplace.
    Spake A
    US News World Rep; 2002 Nov; 133(19):42, 44-6, 48-50. PubMed ID: 12501474
    [No Abstract]   [Full Text] [Related]  

  • 39. Association between premenopausal progestogen use and postmenopausal hormonal therapy in the GAZEL cohort.
    Ringa V; Fritel X; Varnoux N; Zins M; Piault S; Quelen C
    Maturitas; 2007 Nov; 58(3):216-25. PubMed ID: 17919857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guidelines for the hormone treatment of women in the menopausal transition and beyond. Position statement by the Executive Committee of the International Menopause Society.
    Wright J; Naftolin F; Schneider HP; Sturdee DW;
    Maturitas; 2004 May; 48(1):27-31. PubMed ID: 15223105
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.